Cargando…
GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets
With millions of cases diagnosed annually and high economic burden to cover expensive costs, cancer is one of the most difficult diseases to treat due to late diagnosis and severe adverse effects from conventional therapy. This creates an urgent need to find new targets for early diagnosis and thera...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746843/ https://www.ncbi.nlm.nih.gov/pubmed/33344222 http://dx.doi.org/10.3389/fonc.2020.537311 |